Stock-Based Compensation | 5. Stock-Based Compensation The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 were as follows (in thousands): Thirteen Weeks Ended Thirty-Nine Weeks Ended October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Stock-based compensation expense by type: Stock options $ - $ 16 $ 384 $ 375 Restricted stock unit awards, including performance-based 629 815 3,237 3,980 Employee stock purchases 22 23 80 81 Director deferred compensation 24 18 70 53 Total stock-based compensation expense 675 872 3,771 4,489 Income tax benefit recognized 240 316 1,363 1,645 Stock-based compensation expense, net of income tax $ 435 $ 556 $ 2,408 $ 2,844 In the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015, we granted the following equity awards: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Stock options - 1,515 36,359 21,743 Restricted stock unit awards - - 100,775 69,529 Performance-based restricted stock unit awards - - 45,300 29,300 Deferred stock units 588 500 14,744 12,128 At October 29, 2016, the total compensation costs, related to nonvested restricted stock unit awards not yet recognized was $8.7 million and the weighted-average period over which such awards are expected to be recognized was 2.4 years. There are no future compensation costs related to nonvested stock options to be recognized at October 29, 2016. Under the 2012 Non-Employee Director Equity Plan (2012 Plan), no shares of our common stock were awarded during the thirteen weeks ended October 29, 2016 and October 31, 2015. A total of 2,851 and 1,981 shares of our common stock were awarded during the thirty-nine weeks ended October 29, 2016 and October 31, 2015, respectively, as part of the annual equity award to directors in the first quarter. There were no stock options granted during the thirteen weeks ended October 29, 2016. The weighted-average grant date fair value of stock options granted during the thirteen weeks ended October 31, 2015 was $10.52 per shares. The weighted-average grant date fair value of stock options granted during the thirty-nine weeks ended October 29, 2016 and October 31, 2015 was $10.56 and $17.23 per share, respectively. Our employee purchases of common stock, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Shares purchased 3,236 3,114 11,874 8,605 Average price per share $ 29.29 $ 29.76 $ 27.66 $ 36.66 Weighted average fair value at grant date $ 7.25 $ 10.01 $ 6.94 $ 10.35 |